Home Working Groups Chemistry and In Vitro Pharmacology

Sun,19Oct2014

Chemistry and In Vitro Pharmacology

Working Group 3: Chemistry and in vitro pharmacology of gasotransmitter-modifying molecules

Working Group Leader: Giuseppe Cirino (Naples, Italy)Altenhoefer, Sebastian (Maastricht, Netherlands)

  • Andreadou, Ioanna (Athens, Greece)
  • Asimakopoulou Antonia (Patras, Greece)
  • Bucci, Mariarosaria (Naples, Italy)
  • Caliendo, Giuseppe (Naples, Italy)
  • Cirino, Giuseppe (Naples, Italy)
  • Fleming, Ingrid (Frankfurt, Germany)
  • Giannis, Athanassios (Leipzig, Germany)
  • Francesco Grassi (Bologna, Italy)
  • Hobbs, Adrian (London, UK)
  • Jozkowicz, Alicja (Krakow, Poland)
  • Lamas, Santiago (Madrid, Spain)
  • Lefebvre, Romain (Gent, Belgium)
  • Levente, Kiss (Budapest, Hungary)
  • Mayer, Bernd (Gratz, Austria)
  • Nagy, Peter, (Budapest, Hungary)
  • Motterlini, Roberto (Paris, France)
  • Ondrias, Karol (Bratislava, Slovakia)
  • Panopoulos, Panagiotis (Patras, Greece)
  • Papapetropouos, Andreas (Patras, Greece)
  • Perry, Alexis (Exeter, UK)
  • Romao, Carlos (Lisbon, Portugal)
  • Santagada, incenzo (Naples, Italy)
  • Schatzschneider, Ulrich (Würzburg, Germany)
  • Schinzel, Reinhard (Würzburg, Germany)
  • Spyroulias, George (Patras, Greece)
  • Topouzis, Stavros (Patras, Greece)
  • Whiteman, Matt (Exeter,UK)
  • Wood, Mark (Exeter, UK)
  • Zhou, Zongmin (Athens, Greece)

ESF

COST

POLICY STATEMENT: Biomedicine and Molecular Biosciences Action BM1005 is funded by COST, through its implementing agent the European Science Foundation.